Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused

Med J Aust. 2007 Nov 19;187(10):548-9. doi: 10.5694/j.1326-5377.2007.tb01412.x.

Abstract

Australian health systems must rise to the challenge of providing thrombolysis to more stroke patients.

Publication types

  • Editorial

MeSH terms

  • Brain Ischemia / drug therapy*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator